A new HHS federal notice restricting benefit access for undocumented and lawfully present immigrants has triggered criticism from advocacy groups and legal challenges. Democratic attorneys general filed suit against HHS and CMS, asserting that the rule jeopardizes Affordable Care Act access and harms vulnerable populations. The controversy spotlights ongoing tensions around federal healthcare eligibility policies and immigrant rights within the biotech and healthcare policy landscape.